Page last updated: 2024-10-26

emodin and Experimental Mammary Neoplasms

emodin has been researched along with Experimental Mammary Neoplasms in 2 studies

Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Lau, YK1
Xia, W1
Hortobagyi, GN1
Hung, MC1
Morita, H1
Umeda, M1
Masuda, T1
Ueno, Y1

Other Studies

2 other studies available for emodin and Experimental Mammary Neoplasms

ArticleYear
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Division; Disease Models, An

1999
Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FM3A cells.
    Mutation research, 1988, Volume: 204, Issue:2

    Topics: Animals; Anthraquinones; Cell Survival; Emodin; Female; Mammary Neoplasms, Experimental; Mice; Mice,

1988